|Day Low/High||11.28 / 11.62|
|52 Wk Low/High||9.60 / 12.97|
Trial Results to be Presented at American Academy of Dermatology Meeting
The chief commercial officer of the Dublin drugmaker describes the long-term outlook for the medical aesthetics business as 'exceptional.'
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.